Cite
Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
MLA
Chueh-Chuan Yen, et al. Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22489658.
APA
Chueh-Chuan Yen, Ann-Lii Cheng, Ting-Fang Kung, Meng-Chi Hsu, Mei-Lu Chen, Jhe-Cyuan Guo, San-Chi Chen, Chih-Wei Yu, Koping Chang, Jen-Chieh Lee, Ruey-Long Hong, Chia-Lang Hsu, & Tom Wei-Wu Chen. (2023). Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma. https://doi.org/10.1158/1078-0432.22489658
Chicago
Chueh-Chuan Yen, Ann-Lii Cheng, Ting-Fang Kung, Meng-Chi Hsu, Mei-Lu Chen, Jhe-Cyuan Guo, San-Chi Chen, et al. 2023. “Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma,” April. doi:10.1158/1078-0432.22489658.